Absci Corporation (ABSI)

NASDAQ: ABSI · IEX Real-Time Price · USD

4.20

-0.40 (-8.70%)

At close: Dec 29, 2023, 4:00 PM

4.21

+0.01 (0.24%)

After-hours: Dec 29, 2023, 7:56 PM EST

Company Description

Absci Corporation operates as a generative AI drug creation company in the United States.

Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates.

The company was founded in 2011 and is headquartered in Vancouver, Washington.

Absci Corporation

Address: 18105 Se Mill Plain Blvd Vancouver, Washington 98683 United States
Phone	(360) 949-1041
Website	absci.com

Name	Position
Sean McClain	Founder, Chief Executive Officer, President and Director
Dr. Sarah Korman J.D., Ph.D.	Chief Legal Officer and Corporate Secretary
Gregory T. Schiffman CPA, CPA, MBA	Chief Financial Officer
Todd Bedrick CPA	Senior Vice President and Chief Accounting Officer
Jack Gold	Chief Marketing Officer
Melissa Patterson Ph.D.	Chief of Staff
Denise Dettore	Chief People Officer
Dr. Andreas Busch Ph.D.	Chief Innovation Officer
Jonathan Eads M.S.	Senior Vice President of Informatics
Thomas Wrona J.D., Ph.D.	Senior Vice President of Intellectual Property